Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Infliximab for the Treatment of Immune Checkpoint Inhibitor-Associated Acute Kidney Injury.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 29, 2026
Comparative Analysis of Characteristics and Outcomes of Patients with Early-Onset Versus Average-Onset Small Bowel Neuroendocrine Tumors.
Journal: American journal of clinical oncology
Published: August 06, 2026
Outcomes With Peptide Receptor Radionuclide Therapy in Patients With Pheochromocytoma/Paraganglioma: A Center of Excellence Experience.
Journal: American journal of therapeutics
Published: June 16, 2026
Care Patterns and Gastric Cancer-Related Outcomes in Patients With Pathogenic/Likely Pathogenic Germline CDH1 Variants: A 14-Year Single-Center Analysis.
Journal: American journal of clinical oncology
Published: May 04, 2026
Endothelial ACKR1 expression regulates neutrophil infiltration and breast cancer metastatic engraftment in the lung metastatic niche.
Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026
Interfacial Redox Recycling Nanocatalysts with Ultrahigh Peroxidase Activity for Colorimetric Sensing Applications.
Journal: ACS applied nano materials
Published: March 23, 2026
Premature discontinuation of clinical trials in biliary tract cancers: Predictors and implications.
Journal: Journal of cancer policy
Published: January 11, 2026
Symptom burden and outcomes among patients with early-onset versus average-onset neuroendocrine neoplasms.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: November 27, 2025
From infestation to infection: a systematic review of arthropod-mediated microbial transmission in hospitals.
Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE
Published: October 24, 2025
EXTRA-PC: a phase II trial of masofaniten (EPI-7386) and enzalutamide for patients with treatment-naïve metastatic hormone-sensitive prostate cancer.
Journal: The oncologist
Published: October 11, 2025
Precision oncology promise in the management of pancreatic acinar cell carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 23, 2025
Last Updated: 09/26/2026